BSE - SMEListed
Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited

Company website
Subscription runs from 09-07-2025 to 11-07-2025, with allotment expected on 14-07-2025.
Asston Pharmaceuticals Limited is seeking ₹22,41,000 crore — a fresh issue of ₹22,41,000 crore plus OFS of ₹0 crore. Expect market interest to determine final listing performance.
Start Date09-07-2025
End Date11-07-2025
Listing Date16-07-2025
Allotment Date14-07-2025
Current Price₹119
GMP₹26 (21.14%)
Lot Size1000 Shares
Subscription186.59 Times
Face Value₹10 per share
Listing atBSE
Issue Price₹115 - ₹123
Pre Issue₹62,71,360
Post Issue₹85,12,360
Issue Size₹22,41,000
(aggregating up to 27.56 Cr)
Fresh Issue₹22,41,000
(aggregating up to 27.56 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Asston Pharmaceuticals Limited is currently around ₹26 (21.14%). This indicates an estimated listing price of approximately ₹141 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
24 Nov 2025, 10:38
₹123
₹26
₹149 (21.14%)
12 Nov 2025, 08:33
₹123
₹26
₹149 (21.14%)
16 Jul 2025, 04:23
₹123
₹26
₹149 (21.14%)
15 Jul 2025, 04:22
₹123
₹25
₹148 (20.33%)
14 Jul 2025, 12:24
₹123
₹22
₹145 (17.89%)
11 Jul 2025, 12:23
₹123
₹30
₹153 (24.39%)
10 Jul 2025, 11:55
₹123
₹30
₹153 (24.39%)
09 Jul 2025, 12:53
₹123
₹20
₹143 (16.26%)
08 Jul 2025, 06:57
₹123
₹10
₹133 (8.13%)
04 Jul 2025, 12:34
₹123
₹10
₹133 (8.13%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Asston Pharmaceuticals Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIMar-25Mar-24Mar-23
EPS
2.11
6.9
2.37
ROE
69.73
50.56
32.47
ROCE
79.46
51.25
34.29
RONW
40.36
21.28
53.21
PRE IPO(PE)
0
17.83
0
POST IPO(PE)
13.2
0
0

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹5.23
0
0.00
RETAIL
₹9.18
1.16
0.13
HNIs 2+
₹1.33
0.34
0.26
HNIs 10+
₹2.64
0
0.00
Total
₹10.51
1.50
0.14

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
RETAIL
373
64,208
172.14
HNIs(10L +)
72
8,616
119.67
HNIs (2-10L)
36
6,457
179.36
Total
481
79,281
164.83
The IPO reservation for Asston Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
RETAIL
33.29%
7,46,000
BHNI
9.58%
2,14,667
SHNI
4.79%
1,07,333
Anchor
28.34%
6,35,000
QIB
18.96%
4,25,000
MARKET MAKER
5.04%
1,13,000
TOTAL
100.00%
22,41,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
2
2,000
₹2,46,000
0
sHNI
3
3,000
₹3,69,000
0
bHNI
9
9,000
₹11,07,000
0
Below you can find the official contact details of Asston Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 22 49731411
Address: 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614

IPO Registrar

Name: Maashitla Securities Private Limited
Phone: +91-11-45121795